Why the study?
Evidence regarding autonomic nervous system activity at rest in ME/CFS is conflicting, and few attempts have been made to study ANS responses to physical exercise despite severe exercise intolerance being a core feature.
Does an acute exercise bout reveal impaired autonomic nervous system activation in patients with ME/CFS compared to healthy controls?
Does an acute exercise bout reveal impaired autonomic nervous system activation in patients with ME/CFS compared to healthy controls?
ME/CFS patients exhibit reduced parasympathetic reactivation following exercise, highlighting autonomic dysfunction as a potential contributor to exercise intolerance.
Answers are grounded in this paper and cite their sources.
Autonomic dysfunction may contribute to ME/CFS exercise intolerance; hypothesis-generating and requires prospective confirmation before clinical adoption.
Although autonomic nervous system (ANS) dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) has been proposed, conflicting evidence makes it difficult to draw firm conclusions regarding ANS activity at rest in ME/CFS patients. Although severe exercise intolerance is one of the core features of ME/CFS, little attempts have been made to study ANS responses to physical exercise. Therefore, impairments in ANS activation at rest and following exercise were examined using a case-control study in 20 ME/CFS patients and 20 healthy people. Different autonomous variables, including cardiac, respiratory, and electrodermal responses were assessed at rest and following an acute exercise bout. At rest, parameters in the time-domain represented normal autonomic function in ME/CFS, while frequency-domain parameters indicated the possible presence of diminished (para)sympathetic activation. Reduced parasympathetic reactivation during recovery from exercise was observed in ME/CFS. This is the first study showing reduced parasympathetic reactivation during recovery from physical exercise in ME/CFS. Delayed HR recovery and/or a reduced HRV as seen in ME/CFS have been associated with poor disease prognosis, high risk for adverse cardiac events, and morbidity in other pathologies, implying that future studies should examine whether this is also the case in ME/CFS and how to safely improve HR recovery in this population.
No takes yet. Share an insight, caveat, or question.
Oosterwijck et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: